Quarterly Report • Feb 26, 2021
Quarterly Report
Open in ViewerOpens in native device viewer
Regulated information – Inside information
Brussels, 26 February 2021 – 07:00 CET
Olivier Chapelle (CEO): "After a -17.5% sales decline in 1H2020 caused by the COVID-19 lockdown, the 2H2020 was marked by significant sales fluctuations varying from one business segment or country to another, influenced by the subsequent waves of the COVID pandemic and the related precautionary measures taken by national governments. In this difficult context, we managed to generate a robust 7.0% sales growth in 2H2020 and a 10.0% increase in Adjusted EBITDA.
Numerous 'force majeure' events at the premises of our chemical raw material suppliers have created and continue to create supply shortages of polyols and isocyanates. Our suppliers have used this situation to implement price increases at an historically high pace, leading to new all-time highs. In response to this, we were compelled to mitigate these cost increases through corresponding sale price increases. The situation is expected to normalize as of 3Q2021.
2020 has also been a milestone year for the important strategic repositioning of our Group. We have at last succeeded in divesting our Automotive Interiors operations, which, together with the disposal of our 50% participation in the Eurofoam joint venture, has enabled the signing of the acquisition of FoamPartner. This transaction will create a truly global playerin Engineered Foams, and the preparation of its closing is progressing well.
While pursuing further external growth opportunities, the Board of Directors has now also decided to launch a divestment process for our Bedding division, in line with our amended strategy."
1
Our underlying end-use markets remain difficult to predict in the context of the COVID-19 pandemic. Regardless of these uncertainties, ourGroupexpects in 2021 a substantial increase insales, and a 30% increase of its Adjusted EBITDA, not taking into account the contribution from the FoamPartner acquisition nor the related synergies.
To facilitate comparisons and understanding of the Group's underlying performance, all comments in this document on developments in revenue or results are made on a like-for-like basis unless otherwise indicated.
Following the partial divestment from Automotive Interiors on 30 June 2020 (see press release of 01 July 2020), Automotive Interiors is integrated in the consolidated accounts according to the 'equity method'. Following the loss of control as a result of the partial divestment of Automotive Interiors and the sale of Eurofoam, the 2019 consolidated income statement was restated to present these as discontinued operations.
| in million EUR | 2H2019 | 2H2019 | 2H2020 | D % | FY2019 | FY2019 | FY2020 | D % |
|---|---|---|---|---|---|---|---|---|
| Sales | as published 502.4 |
restated 1 424.7 |
454.5 | 7.0% | as published 1 038.5 |
restated 1 878.5 |
828.8 | -5.7% |
| Gross profit | 89.9 | 80.7 | 91.7 | 13.6% | 191.1 | 168.7 | 157.0 | -6.9% |
| as % of sales | 17.9% | 19.0% | 20.2% | 18.4% | 19.2% | 18.9% | ||
| Income from associates 3 | 4.5 | 0.6 | 0.3 | -53.8% | 9.3 | 1.3 | 0.7 | -45.7% |
| Adjusted EBITDA | n.a. | 36.1 | 39.8 | 10.0% | n.a. | 70.7 | 58.8 | -16.8% |
| as % of sales | 8.5% | 8.7% | 8.1% | 7.1% | ||||
| EBITDA | 42.0 | 30.3 | 34.2 | 12.9% | 95.3 | 60.7 | 51.6 | -15.0% |
| as % of sales | 8.4% | 7.1% | 7.5% | 9.2% | 6.9% | 6.2% | ||
| Adjusted operating profit (loss) | n.a. | 18.0 | 22.6 | 25.5% | n.a. | 34.8 | 23.5 | -32.5% |
| as % of sales | 4.2% | 5.0% | 4.0% | 2.8% | ||||
| Operating profit (loss) | 12.4 | 12.1 | 16.7 | 37.9% | 37.1 | 24.4 | 13.8 | -43.3% |
| as % of sales | 2.5% | 2.9% | 3.7% | 3.6% | 2.8% | 1.7% | ||
| Financial result | ( 3.6) | ( 1.4) | ( 2.6) | 79.1% | ( 8.2) | ( 4.2) | ( 5.1) | 21.9% |
| Income from other associates 3 | - | ( 1.6) | ( 2.8) | n.m. | - | 1.0 | ( 5.8) | n.m. |
| Impairment other associates | - | 0.0 | ( 5.5) | n.m. | - | 0.0 | ( 5.5) | n.m. |
| Change in fair value of option structures | - | 0.9 | ( 0.6) | n.m. | - | 3.8 | 1.1 | n.m. |
| Income taxes | ( 0.2) | 1.7 | ( 2.0) | -213.3% | ( 4.2) | ( 0.9) | ( 4.0) | 354.3% |
| Result of the period of the continuing operations | 8.6 | 11.7 | 3.2 | -72.7% | 24.7 | 24.0 | ( 5.5) | -123.0% |
| Result of the discontinued operations | 0.0 | ( 3.1) | ( 0.1) | n.m. | 0.0 | 0.7 | 68.7 | n.m. |
| Result of the period (share of the Group) | 8.7 | 8.7 | 3.0 | -64.9% | 24.8 | 24.8 | 63.2 | 155.0% |
| Result of the period (share of the Group) - base (per share, in EUR) |
0.16 | 0.16 | 0.04 | -73.3% | 0.45 | 0.45 | 1.13 | 153.5% |
| 31 Dec 2019 | 31 Dec 2019 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2019 | 31 Dec 2020 | |||
| Total Equity | 275.4 | 275.4 | 334.8 | 21.6% | 275.4 | 275.4 | 334.8 | 21.6% |
| Net Financial Debt (incl. IFRS 16 - Leases) | 2 168.6 |
2 96.7 |
4.6 | -95.2% | 2 2 168.6 |
2 96.7 |
4.6 | -95.2% |
| Gearing ratio (Net financial debt/Total Equity) | 61.2% | 35.1% | 1.4% | 61.2% | 35.1% | 1.4% | ||
| Leverage ratio (Net financial debt/EBITDA) | 2.0 | 1.6 | 0.1 | 1.8 | 1.6 | 0.1 |
2 Excluding the draw n amounts under non-recourse factoring programs: EUR 0.0 million per 31 December 2020 versus EUR 47.0 million per 31 December 2019 and EUR 0.0 million per 30 June 2020
3 Income from associates = income from associates considered as being part of the Group's core business are integrated in Operating profit (loss); i.e. Orsafoam Income from other associates = income from associates not considered as being part of the Group's core business are not integrated in Operating profit (loss); i.e. Proseat and Automotive Interiors
The following changes in the scope of consolidation took place in 2020:
Consequently, the 1H2020 net result of the Automotive Interiors activities and Eurofoam are reported under discontinued operations and the 2H2020 net result of Automotive Interiors is included under 'Income from other associates'.
The Automotive segment is no longer reported separately.
Sales of chemical raw materials at cost to the Proseat and Automotive Interiors companies, which were reported under the segment Automotive until 2019, are now integrated under "Corporate/Eliminations".
Net Sales: on a like-for-like basis1 sales decreased by 5.7% from EUR 878.5 million1 to EUR 828.8 million, including a currency impact of -0.3%.
Sales recovered strongly in the second half-year (+7.0% y/y), after a first half-year severely impacted by the first wave of the COVID-19 pandemic (-17.5% y/y). Despite the development of a second COVID-19 wave since the autumn, sales increased over the third (+2.5%) and fourth quarter (+11.5%), supported by recovering volumes and higher selling prices, compensating for the steep increase in chemical raw material costs induced by many force majeure events at our main suppliers.
| majeure events at our main suppliers. |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown of the sales by segment | |||||||||||||
| FY2019 D in million EUR 1Q2020 2Q2020 3Q2020 4Q2020 FY2020 FY restated 1 |
|||||||||||||
| Flexible Foams | 361.1 | 89.4 | 57.7 | 81.5 | 93.3 | 322.0 | -10.8% | ||||||
| Bedding | 242.3 | 65.2 | 44.0 | 68.3 | 64.3 | 241.8 | -0.2% | ||||||
| Insulation | 247.2 | 60.7 | 52.0 | 65.0 | 71.5 | 249.2 | 0.8% | ||||||
| Corporate / Eliminations | 28.0 | 6.2 | ( 1.0) | 2.6 | 8.0 | 15.8 | -43.5% | ||||||
| TOTAL CONSOLIDATED SALES 878.5 221.5 152.8 217.4 237.2 828.8 -5.7% |
| in million EUR | restated 1 | restated 1 | 2020 versus 2019 restated | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1Q2019 | 2Q2019 | 1H2019 | 1Q2020 | 2Q2020 | 1H2020 | D 1Q | D 2Q | D 1H | |
| Flexible Foams | 96.8 | 92.6 | 189.4 | 89.4 | 57.7 | 147.1 | -7.7% | -37.7% | -22.3% |
| Bedding | 64.3 | 55.6 | 119.8 | 65.2 | 44.0 | 109.2 | 1.4% | -20.7% | -8.9% |
| Insulation | 62.5 | 67.4 | 129.8 | 60.7 | 52.0 | 112.7 | -2.9% | -22.8% | -13.2% |
| Corporate / Eliminations | 4.6 | 10.1 | 14.7 | 6.2 | ( 1.0) | 5.2 | 33.3% | -110.2% | -64.9% |
| TOTAL CONSOLIDATED SALES | 228.3 | 225.6 | 453.8 | 221.5 | 152.8 | 374.3 | -3.0% | -32.3% | -17.5% |
| in million EUR | restated 1 | restated 1 | 2020 versus 2019 restated | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 3Q2019 | 4Q2019 | 2H2019 | 3Q2020 | 4Q2020 | 2H2020 | D 3Q | D 4Q | D 2H | |
| Flexible Foams | 84.3 | 87.4 | 171.7 | 81.5 | 93.3 | 174.8 | -3.3% | 6.8% | 1.8% |
| Bedding | 57.8 | 64.6 | 122.4 | 68.3 | 64.3 | 132.5 | 18.1% | -0.6% | 8.2% |
| Insulation | 62.9 | 54.4 | 117.3 | 65.0 | 71.5 | 136.5 | 3.3% | 31.5% | 16.4% |
| Corporate / Eliminations | 7.0 | 6.3 | 13.3 | 2.6 | 8.0 | 10.7 | -62.6% | 28.0% | -19.8% |
| TOTAL CONSOLIDATED SALES | 212.0 | 212.7 | 424.7 | 217.4 | 237.2 | 454.5 | 2.5% | 11.5% | 7.0% |
| in million EUR | restated 1 | restated 1 | 2020 versus 2019 restated | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1H2019 | 2H2019 | FY2019 | 1H2020 | 2H2020 | FY2020 | D 1H | D 2H | D FY | |
| Flexible Foams | 189.4 | 171.7 | 361.1 | 147.1 | 174.8 | 322.0 | -22.3% | 1.8% | -10.8% |
| Bedding | 119.8 | 122.4 | 242.3 | 109.2 | 132.5 | 241.8 | -8.9% | 8.2% | -0.2% |
| Insulation | 129.8 | 117.3 | 247.2 | 112.7 | 136.5 | 249.2 | -13.2% | 16.4% | 0.8% |
| Corporate / Eliminations | 14.7 | 13.3 | 28.0 | 5.2 | 10.7 | 15.8 | -64.9% | -19.8% | -43.5% |
| TOTAL CONSOLIDATED SALES | 453.8 | 424.7 | 878.5 | 374.3 | 454.5 | 828.8 | -17.5% | 7.0% | -5.7% |
All segments reported higher sales during 2H2020:
Sales have grown significantly over 3Q2021 (+18.1%) on the back of a strong orderbook, but 4Q2020 was stable (-0.6% y/y), due to raw material supply constraints.
Adjusted EBITDA margin of 7.1% versus 8.1%1 in 2019.
| Adjusted EBITDA margin of 7.1% | versus 8.1%1 | in 2019. | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Breakdown of the Adjusted EBITDA by segment | |||||||||
| in million EUR | 1H2019 restated 1 |
2H2019 restated 1 |
FY2019 restated 1 |
1H2020 | 2H2020 | FY2020 | D 1H |
D 2H |
D FY |
| Flexible Foams | 18.8 | 18.3 | 37.2 | 10.3 | 18.3 | 28.6 | -45.4% | -0.3% | -23.1% |
| Bedding | 6.9 | 9.9 | 16.9 | 4.5 | 13.7 | 18.2 | -34.6% | 37.7% | 8.0% |
| Insulation | 17.1 | 14.5 | 31.6 | 11.3 | 16.4 | 27.7 | -33.9% | 13.0% | -12.3% |
| Corporate | ( 8.2) | ( 6.7) | ( 14.9) | ( 7.0) | ( 8.6) | ( 15.6) | -14.4% | 29.4% | 5.2% |
| TOTAL | |||||||||
| CONSOLIDATED ADJUSTED EBITDA |
34.6 | 36.1 | 70.7 | 19.1 | 39.8 | 58.8 | -44.9% | 10.0% | -16.8% |
Although COVID-19 particularly impacted Adjusted EBITDA in 1H2020 (-44.9% y/y), a solid recovery was observed in 2H2020, with an Adjusted EBITDA growth of +10.0% y/y.
After a first half during which the negative volume impact could be mitigated to a great extent by cost saving measures and the implementation of temporary unemployment, 2H2020 benefitted from recovering volumes in Insulation and Bedding and disciplined selling price adjustments to compensate for the higher chemical raw material costs.
Many force majeure events have occurred after the restart of the suppliers' production lines which had been stopped during the first lockdown -, and have resulted in an extremely tight supply situation over the last 4 months of the year. The shortage has been invoked by our suppliers to increase their prices at a historical speed, and to new record levels. The Group has implemented selling price increases accordingly to protect its profit margins.
Adjusted operating profit (loss): EUR 23.5 million versus EUR 34.8 million1 in 2019.
Adjusted operating profit (loss) margin of 2.8% versus 4.0%1 in 2019.
| Adjusted operating profit (loss) margin of 2.8% versus 4.0%1 | in 2019. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Breakdown of the Adjusted operating profit (loss) | by segment | ||||||||
| in million EUR | 1H2019 restated 1 |
2H2019 restated 1 |
FY2019 restated 1 |
1H2020 | 2H2020 | FY2020 | D 1H |
D 2H |
D FY |
| Flexible Foams | 12.0 | 11.1 | 23.1 | 3.1 | 11.2 | 14.4 | -73.8% | 1.4% | -37.7% |
| Bedding | 2.5 | 5.7 | 8.2 | 0.0 | 10.2 | 10.2 | -99.4% | 79.1% | 25.5% |
| Insulation | 11.5 | 9.4 | 20.9 | 5.9 | 11.2 | 17.1 | -48.4% | 19.1% | -18.0% |
| Corporate | ( 9.1) | ( 8.2) | ( 17.2) | ( 8.2) | ( 10.0) | ( 18.2) | -9.9% | 22.8% | 5.6% |
| TOTAL ADJUSTED OPERATING PROFIT (LOSS) |
16.8 | 18.0 | 34.8 | 0.9 | 22.6 | 23.5 | -94.7% | 25.5% | -32.5% |
| in million EUR | 1H2019 restated1 |
2H2019 restated1 |
FY2019 restated1 |
1H2020 | 2H2020 | FY2020 |
|---|---|---|---|---|---|---|
| Restructuring charges and provisions | ( 1.1) | ( 5.6) | ( 6.7) | ( 1.4) | ( 0.6) | ( 2.0) |
| Other | ( 3.1) | ( 0.3) | ( 3.4) | ( 0.3) | ( 4.9) | ( 5.2) |
| Total impact on EBITDA | ( 4.2) | ( 5.8) | ( 10.0) | ( 1.7) | ( 5.5) | ( 7.2) |
| Impairments | ( 0.3) | ( 0.1) | ( 0.4) | ( 2.1) | ( 0.4) | ( 2.4) |
| Total impact on Operating profit (loss) |
( 4.5) | ( 5.9) | ( 10.4) | ( 3.8) | ( 5.9) | ( 9.7) |
Adjustments to Operating profit (loss) in 2020 include mainly (i) reorganisation charges in Flexible Foams (EUR 0.9 million) and Bedding (EUR 1.0 million), (ii) due diligence and legal fees and expenses linked to the FoamPartner acquisition - cfr press release of 10 November 2020 - (EUR 4.9 million) and (iii) impairments on idle assets in Flexible Foams in Spain (EUR 1.3 million) and in Bedding following the closure of the Hassfurt plant (Germany) (EUR 1.1 million).
| EBITDA margin of 6.2% versus 6.9%1 | in 2019. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Breakdown of EBITDA | by segment | ||||||||
| in million EUR | 1H2019 restated 1 |
2H2019 restated 1 |
FY2019 restated 1 |
1H2020 | 2H2020 | FY2020 | D 1H |
D 2H |
D FY |
| Flexible Foams | 19.3 | 14.9 | 34.1 | 9.5 | 17.9 | 27.4 | -50.9% | 20.1% | -19.9% |
| Bedding | 6.8 | 9.3 | 16.0 | 3.5 | 13.6 | 17.1 | -47.6% | 46.7% | 7.0% |
| Insulation | 17.1 | 14.4 | 31.4 | 11.2 | 16.3 | 27.5 | -34.3% | 13.4% | -12.5% |
| Corporate | ( 12.7) | ( 8.2) | ( 20.9) | ( 6.8) | ( 13.6) | ( 20.4) | -46.0% | 64.9% | -2.3% |
| TOTAL CONSOLIDATED EBITDA |
30.4 | 30.3 | 60.7 | 17.4 | 34.2 | 51.6 | -42.8% | 12.9% | -15.0% |
Operating profit (loss) margin of 1.7% versus 2.8%1 in 2019.
| Operating profit (loss) margin of 1.7% versus 2.8%1 | in 2019. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Breakdown of Operating profit (loss) | by segment | ||||||||
| in million EUR | 1H2019 restated 1 |
2H2019 restated 1 |
FY2019 restated 1 |
1H2020 | 2H2020 | FY2020 | D 1H |
D 2H |
D FY |
| Flexible Foams | 12.4 | 7.6 | 20.0 | 1.2 | 10.7 | 11.9 | -90.1% | 40.8% | -40.6% |
| Bedding | 2.0 | 5.0 | 7.0 | ( 1.9) | 10.0 | 8.1 | -194.7% | 97.5% | 15.1% |
| Insulation | 11.4 | 9.3 | 20.7 | 5.8 | 11.1 | 16.9 | -48.8% | 19.9% | -18.0% |
| Corporate | ( 13.5) | ( 9.7) | ( 23.3) | ( 8.1) | ( 15.0) | ( 23.1) | -40.2% | 54.2% | -0.8% |
| TOTAL OPERATING PROFIT (LOSS) |
12.3 | 12.1 | 24.4 | ( 2.9) | 16.7 | 13.8 | -123.5% | 37.7% | -43.4% |
Financial result: from EUR -4.2 million1 to EUR -5.1 million:
Net interest charges: EUR -3.4 million – of which EUR -2.1 million relating to leases – versus EUR -2.8 million1 in 2019.
'Other net financial income and expenses': EUR -1.7 million versus EUR -1.4 million1 in 2019. This item comprises mainly interest capitalisation costs under provisions for pension liabilities (EUR -0.3 million versus EUR -0.8 million1 in 2019) and exchange rate differences (EUR -1.4 million versus EUR -0.6 million1 in 2019).
Income from other associates : EUR -5.7 million relates to the reported results in Proseat (EUR -5.1 million) and in Automotive Interiors (EUR -0.6 million).
Fair value of option structures : EUR +1.1 million relates to an adjustment of the fair value of the put/call structure on the 25% Proseat participation. The put/call structure on the remaining 49% participation in the Automotive Interiors joint-venture has been maintained at a 'zero' value given the uncertainties over the period until the earliest exercise date of the options (2024).
The total result of discontinued operations consists of:
| 31 DEC | 31 MAR | 30 JUN | 30 SEP | 31 DEC | |
|---|---|---|---|---|---|
| in million EUR | 2019 | 2020 | 2020 | 2020 | 2020 |
| TOTAL EQUITY | 276.6 | - | 331.5 | - | 334.8 |
| Net financial debt excluding factoring | 88.6 | 121.4 | ( 11.4) | ( 43.7) | ( 47.9) |
| + Drawn amounts under factoring programs | 47.1 | 32.1 | 0.0 | 0.0 | 0.0 |
| + Impact of application IFRS 16 | 80.0 | 77.6 | 55.2 | 52.9 | 52.5 |
| TOTAL CONSOLIDATED NET FINANCIAL DEBT | 215.6 | 231.1 | 43.8 | 9.3 | 4.6 |
| Gearing ratio (incl. IFRS 16 ) | 60.9% | - | 13.2% | - | 1.4% |
| Leverage ratio (incl. IFRS 16) | 1.8 | - | 0.7 | - | 0.1 |
The Group's net cash position - excluding IFRS16 debt - increased by EUR 4.2 million over 4Q2020 to reach EUR 47.9 million.
On 4 December 2020 the Group entered into (i) a new EUR 100 million syndicated revolving credit facility to replace the EUR 175 million 'club deal' facility maturing in February 2021 and (ii) a EUR 205 million acquisition financing facility to finance the acquisition of FoamPartner (cfr press release of 10 November 2020), planned to be closed as soon as all anti-trust approvals will have been obtained.
Both facilities have been arranged and underwritten by KBC Bank. Belfius Bank, BNP Paribas Fortis, Commerzbank and LCL confirmed their participation. Both facilities have a 3-year tenor with two 1-year extension options.
| 3.1. FLEXIBLE FOAMS |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| in million EUR | 1H2019 | 2H2019 | FY2019 | 1H2020 | 2H2020 | FY2020 | D 1H |
D 2H |
D FY |
| restated1 | restated1 | restated1 | |||||||
| Sales | 189.4 | 171.7 | 361.1 | 147.1 | 174.8 | 322.0 | -22.3% | 1.8% | -10.8% |
| Adjusted EBITDA | 18.8 | 18.3 | 37.2 | 10.3 | 18.3 | 28.6 | -45.4% | -0.3% | -23.1% |
| as % of sales | 9.9% | 10.7% | 10.3% | 7.0% | 10.5% | 8.9% | |||
| EBITDA | 19.3 | 14.9 | 34.1 | 9.5 | 17.9 | 27.4 | -50.9% | 20.1% | -19.9% |
| as % of sales | 10.2% | 8.7% | 9.5% | 6.4% | 10.2% | 8.5% | |||
| Adjusted operating profit (loss) | 12.0 | 11.1 | 23.1 | 3.1 | 11.2 | 14.4 | -73.8% | 1.4% | -37.7% |
| as % of sales | 6.3% | 6.5% | 6.4% | 2.1% | 6.4% | 4.5% | |||
| Operating profit (loss) | 12.4 | 7.6 | 20.0 | 1.2 | 10.7 | 11.9 | -90.1% | 40.8% | -40.6% |
| as % of sales | 6.6% | 4.4% | 5.5% | 0.8% | 6.1% | 3.7% |
Sales increased by 6.8% in 4Q2020 from EUR 87.4 million1 in 4Q2019 to EUR 93.3 million, including a -1.7% impact from exchange rate differences. External sales increased by 6.0% from EUR 79.9 million1 to EUR 84.7 million, including the impact of passing on higher chemical raw material costs to the market.
Although market demand restored as of September, COVID-induced sales reduction in 1H2020 (-22.3% on a like-for-like1 basis), could not be compensated during 2H2020 (+1.8%). Sales decreased from EUR 361.1 million1 to EUR 322.0 million (-10.8%), including a -0.9% impact from exchange rate differences. External sales decreased by 12.0% from EUR 332.0 million1 to EUR 292.2 million.
Selling prices were increased as of September 2020 to compensate for the steep surge in chemical raw material prices following several force majeure events and other supply issues in the upstream value chain.
Although profitability gradually improved after Q2, the like-for-like1 Adjusted EBITDA margin decreased to 8.9% (2019: 10.3%1 ). The margin reduction is fully explained by the negative volume impact leading to unabsorbed fixed costs, partially mitigated by cost saving measures, including temporary unemployment and pricing efforts.
EBITDA includes adjustments for EUR -1.2 million (2019: EUR -3.0 million1 ): of which EUR - 0.9 million of restructuring charges in The Netherlands and Spain.
| 3.2. BEDDING |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| in million EUR | 1H2019 | 2H2019 | FY2019 | 1H2020 | 2H2020 | FY2020 | D 1H |
D 2H |
D FY |
| Sales | 119.8 | 122.4 | 242.3 | 109.2 | 132.5 | 241.8 | -8.9% | 8.2% | -0.2% |
| Adjusted EBITDA | 6.9 | 9.9 | 16.9 | 4.5 | 13.7 | 18.2 | -34.6% | 37.7% | 8.0% |
| as % of sales | 5.8% | 8.1% | 7.0% | 4.2% | 10.3% | 7.5% | |||
| EBITDA | 6.8 | 9.3 | 16.0 | 3.5 | 13.6 | 17.1 | -47.6% | 46.7% | 7.0% |
| as % of sales | 5.6% | 7.6% | 6.6% | 3.2% | 10.3% | 7.1% | |||
| Adjusted operating profit (loss) | 2.5 | 5.7 | 8.2 | 0.0 | 10.2 | 10.2 | -99.4% | 79.1% | 25.5% |
| as % of sales | 2.0% | 4.7% | 3.4% | 0.0% | 7.7% | 4.2% | |||
| Operating profit (loss) | 2.0 | 5.0 | 7.0 | ( 1.9) | 10.0 | 8.1 | -194.7% | 97.5% | 15.1% |
| as % of sales | 1.7% | 4.1% | 2.9% | -1.7% | 7.5% | 3.3% |
Sales slightly decreased from EUR 64.6 million in 4Q2019 to EUR 64.3 million in 4Q2020 (- 0.6%), including a +0.7% impact of exchange rate differences. External sales decreased by 0.1% to EUR 63.3 million in 4Q2020.
The strong momentum observed during 3Q2020 (+18.1%) - compensating for the volume shortfall in 2Q2020 (-20.7%) following the COVID-19 retail shopping restrictions imposed in most European countries – lost some of its momentum in 4Q2020 as new mobility restrictions (2nd COVID-19 wave) and raw material shortages dampened intrinsic volume growth.
Over 2020, sales remained stable despite the impact of COVID-19 on the retail sector. Sales amounted to EUR 241.8 million (-0.2%) versus EUR 242.3 million in 2019, including a +0.7% impact from exchange rate differences. External sales increased by 0.4% from EUR 237.3 million to EUR 238.2 million.
The sub-segment "Branded Products" (+3.8%) held firm given the challenging market environment, whereas the sub-segment "Non-Branded/Private Label" receded by 6.4%. Both sub-segments were heavily impacted during the second quarter by the COVID-19 retail shopping restrictions imposed in most European countries.
The Adjusted EBITDA margin reached 7.5% versus 7.0% in 2019. The improved profitability was induced by positive mix effects and lower operating costs.
Despite the COVID-19 crisis, EBITDA increased from EUR 16.0 million to EUR 17.1 million; including non-recurring costs for EUR -1.1 million following the implementation of cost saving measures (2019: EUR -0.9 million).
| 3.3. INSULATION |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| in million EUR | 1H2019 | 2H2019 | FY2019 | 1H2020 | 2H2020 | FY2020 | D 1H |
D 2H |
D FY |
| Sales | 129.8 | 117.3 | 247.2 | 112.7 | 136.5 | 249.2 | -13.2% | 16.4% | 0.8% |
| Adjusted EBITDA | 17.1 | 14.5 | 31.6 | 11.3 | 16.4 | 27.7 | -33.9% | 13.0% | -12.3% |
| as % of sales | 13.1% | 12.4% | 12.8% | 10.0% | 12.0% | 11.1% | |||
| EBITDA | 17.1 | 14.4 | 31.4 | 11.2 | 16.3 | 27.5 | -34.3% | 13.4% | -12.5% |
| as % of sales | 13.1% | 12.3% | 12.7% | 9.9% | 11.9% | 11.0% | |||
| Adjusted operating profit (loss) | 11.5 | 9.4 | 20.9 | 5.9 | 11.2 | 17.1 | -48.4% | 19.1% | -18.0% |
| as % of sales | 8.8% | 8.0% | 8.4% | 5.2% | 8.2% | 6.9% | |||
| Operating profit (loss) | 11.4 | 9.3 | 20.7 | 5.8 | 11.1 | 16.9 | -48.8% | 19.9% | -18.0% |
| as % of sales | 8.8% | 7.9% | 8.4% | 5.2% | 8.1% | 6.8% |
Sales increased from EUR 54.4 million in 4Q2019 to EUR 71.5 million in 4Q2020 (+31.5%), including a -1.5% impact of exchange rate differences.
The sales increase results from strong volume development and selling price increases implemented to compensate for the steep surge in chemical raw material prices following a tighter supply in the upstream supply chain.
The new plant in Finland continues to increase its output.
In 4Q2020 demand for VIP (vacuum insulation panel) material has sharply increased, boosted by demand for ultra-high performance insulation materials needed for the transportation and storage of COVID-19 vaccines.
Despite the impact of COVID-19 – mainly in 2Q2020 –, sales slightly exceeded the level of 2019 thanks to solid demand leading to increased volumes: EUR249.2millionversusEUR 247.2 million to (+0.8%), including a currency impact of -0.5%.
EC stimulus plans and green regulatory incentives will remain a key volume driver in Europe in 2021.
Adjusted EBITDA margin of 11.1% versus 12.8% in 2019.
The profitability decline in 2020 results from (i) lower profit in 1H2020 due to sub-critical asset utilisation linked to COVID-19 impacted volumes, and (ii) higher profit in 2H2020 due to strong volumes, but partially mitigated by steep raw material price increases.
The new Finnish plant ramp-up is progressing well taking into account the COVID-19 impact and is expected to lead to break-even in 2H2021.
The Board of Directors has completed the strategic review of the Bedding business segment and decided to divest the segment in order to focus on the core segments Insulation and Engineered Foams.
Recticel Bedding is a leading European manufacturer and distributor of branded and unbranded mattresses, slats, bed bases and finished beds. The business operates through a distinguished portfolio of brands including Geltex®, Schlaraffia®, Superba®, Swissflex®, Sembella®, Literie Bultex®, Beka® and Lattoflex® sold mainly in Belgium, Germany, the Netherlands, Poland, Austria and Switzerland. The divestment will provide an opportunity for the segment to unlock its full potential under the ownership of a dedicated shareholder.
The next few months will be used to prepare the carve-out. J.P. Morgan has been retained to advise Recticel on the divestment.
The Board of Directors will propose to the Annual General Meeting of 25 May 2021 the payment of a gross dividend of EUR 0.26 per share on 55.7 million shares or a total dividend pay-out of EUR 14.5 million (2019: respectively EUR 0.24/share and EUR 13.3 million in total).
All figures and tables contained in these annexes have been compiled in accordance with the IFRS accounting and valuation principles, as adopted within the European Union. The applied valuation principles, as published in the latest annual report at 31 December 2019, were applied for the figures included in this press release.
The analysis of the risk management is described in the annual report and the IAS 34 Interim report per 30 June 2020, b oth which are available from www.recticel.com.
| Group Recticel | 2019 | 2020 | D |
|---|---|---|---|
| in thousand EUR | restated 1 | ||
| (a) | (b) | (b)/(a)-1 | |
| Sales | 878 521 | 828 792 | -5.7% |
| Distribution costs | ( 55 892) | ( 54 849) | -1.9% |
| Cost of sales | ( 653 965) | ( 616 913) | -5.7% |
| Gross profit | 168 664 | 157 030 | -6.9% |
| General and administrative expenses | ( 58 349) | ( 57 949) | -0.7% |
| Sales and marketing expenses | ( 66 950) | ( 60 624) | -9.4% |
| Research and development expenses | ( 10 643) | ( 9 281) | -12.8% |
| Impairments goodwill, tangible and intangible assets |
( 396) | ( 2 440) | 516.2% |
| Other operating revenues | 8 384 | 15 514 | 85.0% |
| Other operating expenses | ( 17 587) | ( 29 103) | 65.5% |
| Income from associates | 1 294 | 703 | -45.7% |
| Operating profit (loss) | 24 417 | 13 850 | -43.3% |
| Interest income | 2 759 | 909 | -67.1% |
| Interest expenses | ( 5 541) | ( 4 329) | -21.9% |
| Other financial income | 9 273 | 5 294 | -42.9% |
| Other financial expenses | ( 10 711) | ( 7 018) | -34.5% |
| Financial result | ( 4 220) | ( 5 144) | 21.9% |
| Income from other associates | 962 | ( 5 790) | -701.9% |
| Impairments other associates | 0 | ( 5 525) | n.m. |
| Change in fair value of option structures | 3 762 | 1 103 | -70.7% |
| Result of the period before taxes | 24 921 | ( 1 506) | -106.0% |
| Income taxes | ( 886) | ( 4 025) | 354.3% |
| Result of the period after taxes - continuing operations |
24 035 | ( 5 531) | -123.0% |
| Result of the period after taxes - discontinued operations |
683 | 68 686 | n.m. |
| Result of the period after taxes - continuing and discontinued operations |
24 718 | 63 155 | 155.5% |
| of which attributable to the owners of the parent | 24 762 | 63 151 | 155.0% |
| of which attributable to non-controlling interests | ( 44) | 4 | -109.1% |
A distinction has been made betw een Income from associates - included in operating profit (loss) - and Income from other associates - excluded from operating profit (loss).
Income from associates: income from associates considered as being part of the Group's core business are integrated in Operating profit (loss); i.e. Orsafoam
Income from other associates: income from associates not considered as being part of the Group's core business are not integrated in Operating profit (loss); i.e. Proseat and Automotive Interiors
| in EUR | 2019 restated1 |
2020 | D |
|---|---|---|---|
| Number of shares outstanding (including treasury shares) | 55 070 639 55 742 920 | 1.2% | |
| Weighted average number of shares outstanding (before dilution effect) | 54 959 861 55 174 425 | 0.4% | |
| Weighted average number of shares outstanding (after dilution effect) | 55 154 501 55 381 032 | 0.4% | |
| Continuing operations | |||
| EBITDA | 1.10 | 0.94 | -15.3% |
| Operating profit (loss) | 0.44 | 0.25 | -43.5% |
| Result of the period before taxes | 0.45 | ( 0.03) | n.m. |
| Earnings per share - continuing operations | 0.44 | ( 0.10) | n.m. |
| Earnings per share - discontinued operations | 0.01 | 1.24 | n.m. |
| Earnings per share of continuing and discontinued operations | 0.45 | 1.14 | 154.5% |
| Earnings per share from continuing operations | |||
| Basic | 0.437 | ( 0.100) | n.m. |
| Diluted | 0.436 | ( 0.100) | n.m. |
| Earnings per share from discontinued operations | |||
| Basic | 0.012 | 1.245 | 9918.3% |
| Diluted | 0.012 | 1.240 | 9916.3% |
| Net book value | 5.00 | 6.01 | 20.1% |
| Group Recticel in thousand EUR |
2019 | 2020 |
|---|---|---|
| Result for the period after taxes Other comprehensive income |
24 718 | 63 155 |
| Items that will not subsequently be recycled to profit and loss | ||
| Actuarial gains (losses) on employee benefits recognized in equity | ( 4 333) | 420 |
| Deferred taxes on actuarial gains (losses) on employee benefits | 759 | 0 |
| Currency translation differences | ( 18) | 161 |
| Share in other comprehensive income in joint ventures & associates | ( 655) | ( 262) |
| Total | ( 4 247) | 319 |
| Items that subsequently may be recycled to profit and loss | ||
| Hedging reserves | 0 | ( 70) |
| Currency translation differences Foreign currency translation reserve difference recycled in the income |
371 305 |
( 9 227) 18 311 |
| statement Deferred taxes on retained earnings |
( 68) | ( 113) |
| Share in other comprehensive income in joint ventures & associates Total |
158 766 |
( 2 098) 6 803 |
| Other comprehensive income net of tax | ( 3 481) | 7 122 |
| Total comprehensive income for the period | 21 237 | 70 277 |
| Total comprehensive income for the period | 21 237 | 70 277 |
| of which attributable to the owners of the parent of which attributable to non-controlling interests |
21 243 ( 6) |
70 273 4 |
| Group Recticel in thousand EUR |
31 Dec 2019 as published |
31 Dec 2020 |
|---|---|---|
| Intangible assets | 14 306 | 14 806 |
| Goodwill | 24 412 | 24 139 |
| Property, plant & equipment | 227 617 | 173 000 |
| Right-of-use assets | 105 110 | 75 377 |
| Investment property | 3 331 | 3 331 |
| Investments in associates | 54 512 | 12 351 |
| Investments in other associates | 10 953 | 11 030 |
| Non-current receivables | 26 383 | 25 760 |
| Other non-current contract assets | 11 138 | 0 |
| Deferred taxes | 24 108 | 25 298 |
| Non-currrent assets | 501 869 | 365 092 |
| Inventories | 101 797 | 90 833 |
| Trade receivables | 99 117 | 102 726 |
| Other current contract assets | 11 300 | 0 |
| Other receivables and other financial assets | 32 667 | 57 929 |
| Income tax receivables | 1 448 | 1 452 |
| Other investments | 154 | 170 |
| Cash and cash equivalents | 48 479 | 79 255 |
| Assets held for sale | 5 638 | 1 300 |
| Current assets | 300 600 | 333 665 |
| TOTAL ASSETS | 802 469 | 698 757 |
| Capital | 138 494 | 139 357 |
| Share premium | 130 334 | 131 267 |
| Share capital | 268 828 | 270 624 |
| Treasury shares | ( 1 450) | ( 1 450) |
| Other reserves | ( 25 621) | ( 22 487) |
| Retained earnings | 51 227 | 98 760 |
| Hedging and translation reserves | ( 18 288) | ( 11 372) |
| Equity (share of the Group) | 274 696 | 334 075 |
| Equity attributable to non-controlling interests | 701 | 705 |
| Total equity | 275 397 | 334 780 |
| Pensions and similar obligations | 57 860 | 52 342 |
| Provisions | 6 905 | 18 979 |
| Deferred taxes | 10 023 | 12 173 |
| Financial liabilities | 100 334 | 70 426 |
| Non-current contract liabilities | 20 339 | 0 |
| Other amounts payable | 43 | 26 |
| Non-current liabilities | 195 504 | 153 946 |
| Provisions | 5 759 | 1 598 |
| Financial liabilities | 117 415 | 14 403 |
| Trade payables | 93 008 | 88 923 |
| Current contract liabilities | 32 832 | 15 183 |
| Income tax payables | 1 229 | 1 045 |
| Other amounts payable | 81 325 | 88 879 |
| Current liabilities | 331 568 | 210 031 |
| TOTAL EQUITY AND LIABILITIES | 802 469 | 698 757 |
| Group Recticel in thousand EUR |
2019 restated |
2020 |
|---|---|---|
| Operating profit (loss) | 24 417 | 13 848 |
| Income from discontinued operations | 683 | 68 692 |
| Depreciation, amortisation and impairment losses on assets | 58 070 | 49 673 |
| Write-offs (-back) on assets and shares of affiliates | 667 | 1 359 |
| Changes in provisions | -6 740 | 7 617 |
| (Gain)/Loss on disposal of assets | -3 740 | - 132 |
| (Gain)/Loss on disposal of shares | 0 | -101 674 |
| Income from associates | -1 294 | - 704 |
| Other non-cash elements | 273 | 607 |
| Gross operating cash flow | 72 336 | 39 286 |
| Changes in working capital and long-term receivables | -1 668 | -30 952 |
| Gross operating cash flow after changes in working capital | 70 668 | 8 334 |
| Income taxes paid | -3 899 | -5 188 |
| Net cash flow from operating activities (a) | 66 768 | 3 146 |
| Net cash flow from investment activities (b) | -30 717 | 165 669 |
| Paid interest charges on financial debt (c) | -2 453 | -2 147 |
| Paid interest charges on lease debt | - 146 | - 125 |
| Paid dividends | -13 163 | -13 254 |
| Increase (Decrease) of capital | 819 | 1 797 |
| Increase of financial debt | 51 169 | 97 523 |
| Decrease of financial debt | -13 151 | -202 895 |
| Reimbursement of lease liabilities (d) | -24 466 | -20 573 |
| Net cash flow from financing activities (e) | -1 391 | -139 674 |
| Effect of exchange rate changes (f) | - 697 | 1 635 |
| Changes in cash and cash equivalents (a)+(b)+(e)+(f) | 33 963 | 30 776 |
| FREE CASH FLOW (a)+(b)+(c)+(d) | 8 987 | 145 970 |
| Group Recticel in thousand EUR |
Capital | Share premium Treasury shares Other reserves | Retained earnings |
Translation differences reserves and Hedging reserves |
Total shareholders' equity |
Non-controlling interests |
Total equity, non controlling interests included |
||
|---|---|---|---|---|---|---|---|---|---|
| At the end of the period 31 December 2019 |
138 494 | 130 334 | -1 450 | -25 621 | 51 227 | -18 288 | 274 696 | 701 | 275 397 |
| Dividends | 0 | 0 | 0 | 0 | -13 299 | 0 | -13 299 | 0 | -13 299 |
| Stock options (IFRS 2) | 0 | 0 | 0 | 609 | 0 | 0 | 609 | 0 | 609 |
| Capital movements | 863 | 933 | 0 | 0 | 0 | 0 | 1 796 | 0 | 1 796 |
| Shareholders' movements | 863 | 933 | 0 | 609 | -13 299 | 0 | -10 894 | 0 | -10 894 |
| Profit or loss of the period | 0 | 0 | 0 | 0 | 63 151 | 0 | 63 151 | 4 | 63 155 |
| Other comprehensive income' | 0 | 0 | 0 | 319 | - 107 | -11 401 | -11 189 | 0 | -11 189 |
| Change in scope | 0 | 0 | 0 | 2 145 | -2 145 | 18 311 | 18 311 | 0 | 18 311 |
| Comprehensive income | 0 | 0 | 0 | 2 464 | -2 252 | 6 910 | 7 122 | 0 | 7 122 |
| Reclassification | 0 | 0 | 0 | 61 | - 61 | 0 | 0 | 0 | 0 |
| At the end of the period 31 December 2020 |
139 357 | 131 267 | -1 450 | -22 487 | 98 766 | -11 378 | 334 075 | 705 | 334 780 |
| Group Recticel | 31 DEC 2019 | 31 DEC 2020 |
|---|---|---|
| in thousand EUR Income statement |
restated 1 | |
| Sales | 878 521 | 828 793 |
| Gross profit | 168 664 | 154 474 |
| EBITDA | 60 715 | 51 609 |
| Operating profit (loss) | 24 417 | 13 848 |
| Operating profit (loss) | 24 417 | 13 848 |
| Amortisation intangible assets Depreciation tangible assets |
1 942 33 018 |
1 933 32 377 |
| Amortisation deferred charges long term | 943 | 1 011 |
| Impairments on goodwill, intangible and tangible fixed assets | 395 | 2 439 |
| EBITDA | 60 715 | 51 609 |
| EBITDA | 60 715 | 51 609 |
| Restructuring charges | 6 654 | 2 034 |
| Other | 3 375 | 5 198 |
| Adjusted EBITDA | 70 744 | 58 841 |
| Operating profit (loss) | 24 417 | 13 848 |
| Restructuring charges | 6 654 | 2 034 |
| Other Impairments |
3 375 395 |
5 198 2 439 |
| Adjusted Operating profit (loss) | 34 841 | 23 519 |
| 31 DEC 2019 | ||
| Total net financial debt | as published | 31 DEC 2020 |
| Non-current financial liabilities Current financial liabilities |
100 334 117 415 |
70 426 14 403 |
| Cash | ( 48 479) | ( 79 255) |
| Other financial assets 1 | ( 712) | ( 999) |
| Net financial debt on statement of financial position | 168 558 | 4 575 |
| Factoring programs Total net financial debt |
47 051 215 609 |
0 4 575 |
| 1 Hedging instruments and interest advances |
||
| Gearing ratio (Net financial debt / Total equity) | ||
| Total equity | 275 397 | 334 780 |
| Net financial debt on statement of financial position / Total equity | 61.2% | 1.4% |
| Total net financial debt / Total equity | 78.3% | 1.4% |
| Leverage ratio (Net financial debt / EBITDA) | ||
| EBITDA (last 12 months) | 60 715 | 51 609 |
| Net financial debt on statement of financial position / EBITDA | 2.8 | 0.1 |
| Total net financial debt / EBITDA | 3.6 | 0.1 |
| Net working capital | ||
| Inventories and contracts in progress | 101 797 | 90 833 |
| Trade receivables Current contract assets |
99 117 11 300 |
102 726 0 |
| Other receivables | 32 667 | 57 929 |
| Income tax receivables | 1 449 | 1 452 |
| Trade payables | ( 93 008) | ( 88 923) |
| Current contract liabilities Income tax payables |
( 32 832) ( 1 229) |
( 15 183) ( 1 045) |
| Other amounts payable | ( 81 325) | ( 88 879) |
| Net working capital | 37 936 | 58 910 |
| Current ratio (= Current assets / Current liabilities) | ||
| Current assets Current liabilities |
300 600 332 264 |
333 665 210 031 |
| Current ratio (factor) | 0.9 | 1.6 |
The statutory auditor, Deloitte Bedrijfsrevisoren CVBA, represented by Kurt Dehoorne, has confirmed that the audit, which is substantially complete, has not to date revealed any material misstatement in the draft consolidated income statement, consolidated statement of total comprehensive income, consolidated statement of financial position and consolidated statement of cash flows, and that the accounting data reported in the press release is consistent, in all material respects, with the draft consolidated income statement, consolidated statement of total comprehensive income, consolidated statement of financial position and consolidated statement of cash flows from which it has been derived.
Consolidated (data) : financial data follow ing the application of IFRS 11, w hereby joint ventures and associates are integrated on the basis of the equity method.
In addition, the Group uses alternative performance measures (Alternative Performance Measures or "APM") to express its underlying performance and to help the reader to better understand the results. APM are not defined performance indicators by IFRS. The Group does not present APM as an alternative to financial measures determined in accordance w ith IFRS and does not give more emphasis to APM than the defined IFRS financial measures.
Adjusted EBITDA : EBITDA before Adjustments (to Operating Profit)
Adjusted operating profit (loss) : Operating profit (loss) + adjustments to operating profit (loss)
This press report contains forecasts which entail risks and uncertainties, including with regard to statements concerning plans, objectives, expectations and/or intentions of the Recticel Group and its subsidiaries. Readers are informed that such forecasts entail known and unknown risks and/or may be subject to considerable business, macroeconomic and competition u ncertainties and unforeseen circumstances which largely lie outside the control of the Recticel Group. Should one or more of these risks, uncertainties or unforeseen or unexpected circumstances arise or if the underlying assumptions were to prove to be incorrect, the final financial results of the Group may possibly differ significantly from the assumed, expected, estimated or extrapolated results. Consequently, neither Recticel nor any other person assumes any responsibility for the accuracy of these forecasts.
Annual results 2020 26.02.2021 (at 07:00 AM CET) First quarter 2021 trading update 27.04.2021 (at 07:00 AM CET) Annual General Meeting 25.05.2021 (at 10:00 AM CET) First half-year 2021 results 27.08.2021 (at 07:00 AM CET) Third quarter 2021 trading update 29.10.2021 (at 07:00 AM CET) Annual results 2021 25.02.2022 (at 07:00 AM CET)
| RECTICEL avenue du Bourget/Bourgetlaan 42, 1130 Brussels |
||||
|---|---|---|---|---|
| PRESS | INVESTOR RELATIONS | |||
| Mr Olivier Chapelle | Mr Michel De Smedt | |||
| Tel: +32 2 775 18 01 | Mobile: +32 479 91 11 38 | |||
| [email protected] | [email protected] |
Recticel is a Belgian Group w ith a strong European dimension, but it also operates in the rest of the w orld. Recticel (excluding minority stakes in joint ventures) employs 4,221 people in 41 establishments in 20 countries.
Recticel contributes to daily comfort w ith high performance insulation solutions, mattresses and slat bases of top brands and an extensive range of polyurethane foam products for industrial and domestic applications.
Within Recticel's Insulation segment, the high-quality thermal insulation products are marketed under the w ellknow n brands Eurow all®, Pow erroof®, Pow erdeck®, Pow erw all® and Xentro®. Recticel is also the Group behind the bedding brands (Beka®, Lattoflex®, Literie Bultex®, Schlaraffia®, Sembella®, Sw issflex®, Superba®, etc.) and GELTEX®.
In 2020 Recticel achieved consolidated sales of EUR 828.8 million.
Recticel (Euronext: REC – Reuters: RECTt.BR – Bloomberg: REC:BB) is listed on Euronext in Brussels.
The press release is available in English and Dutch on the website www.recticel.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.